×

Antiviral oligonucleotides

  • US 7,358,068 B2
  • Filed: 09/12/2003
  • Issued: 04/15/2008
  • Est. Priority Date: 09/13/2002
  • Status: Active Grant
First Claim
Patent Images

1. A method for the treatment of a viral infection in a subject, comprising administering to a subject in need of such treatment a therapeutically effective amount of at least one pharmacologically acceptable phosphorothioated oligonucleotide formulation comprising SEQ ID NO:

  • 22 having an antiviral activity, said viral infection being caused by a virus selected from the group consisting of HCV, HBV, Influenza A, RSV, HSV-1, HSV-2, Ebola and CMV, wherein said antiviral activity of said oligonucleotide occurs principally by a sequence independent mode of action.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×